Figure 5.
Knockout of ASPP1 improves cardiac I/R injury. A, Verification of ASPP1 conventional knockout in mice by Western blot (Student t test); n=6. B, Cardiac function of wild type (WT) and ASPP1 knockout (KO) mice after I/R injury by echocardiography (2-way ANOVA, followed by Tukey post hoc multicomparisons test); n=11. C, Infarct area of I/R mice by 2,3,5-triphenyltetrazolium chloride (TTC) staining (Mann-Whitney U test); n=15. Scale bar=2 mm. D and E, Serum LDH (Kruskal-Wallis, followed by false discovery rate [FDR] method of Benjamini and Hochberg test) and creatine kinase isoenzyme MB (CKMB; 2-way ANOVA, followed by Tukey post hoc multicomparisons test) levels; n=13 (WT+Sham and ASPP1[KO]+Sham); n=15 (WT+I/R and ASPP1[KO]+I/R) for LDH assay; n=9 for CKMB assay. F, Caspase-3 activity detected by ELISA assay (2-way ANOVA, followed by Tukey post hoc multicomparisons test); n=9. G and H, The protein levels of Bcl2 and Bax detected by Western blot (2-way ANOVA, followed by Tukey post hoc multicomparisons test); n=6. I, Immunofluorescent staining was performed to analyze the effects of ASPP1 knockout on p53 nuclear translocation in isolated adult cardiomyocytes after cardiac I/R injury (Kruskal-Wallis, followed by FDR method of Benjamini and Hochberg test); n=5; ns, not significant. Scale bar=20 μm. ASPP1 indicates apoptosis stimulating of p53 protein 1; DAPI, 4′,6-diamidino-2-phenylindole; I/R, ischemia/reperfusion; and LDH, lactate dehydrogenase.